Journal: Molecular Neurobiology
Article Title: Mesenchymal Stem Cell-derived Exosomes Alleviate Oxidative Stress and Brain Injuries Through Promoting OPA1 Mediated Mitochondrial Fusion After Intracerebral Hemorrhage
doi: 10.1007/s12035-026-05703-4
Figure Lengend Snippet: Neuron-specific Opa1 deletion blunted the protective effects of MSC-Exo treatment on oxidative stress and neurological outcomes after ICH. A, B Representative images depicting DHE staining and the quantitative assessment of DHE fluorescence intensity within the perilesional domain at 24 h post-intracerebral hemorrhage (ICH) are showcased, with a scale bar of 100 µm ( n = 6 per group, two-way ANOVA). C Effects of MSC-Exo treatment on MDA levels ( n = 6 per group, two-way ANOVA). D, F The reversal of the neuroprotective effects conferred by MSC-Exo in the context of neuronal-specific Opa1 conditional knockout is evaluated through behavioral assessments at various time points post-ICH, encompassing the Grid-walking test, Adhesive removal test, and Cylinder test ( n = 12 per group, two-way ANOVA). G The spatial learning and memory of subjects is further evaluated using the Morris water maze, portraying characteristic swim trajectories during the learning and memory phases of the assessment. H Mean swimming speed of mice in the MWM ( n = 12 per group, two-way ANOVA). I Spatial learning was evaluated through the measurement of escape latency in the Morris water maze from days 21 to 25 post-ICH ( n = 12 per group, two-way ANOVA). J, K Spatial memory is gauged by the duration spent in the target quadrant and the number of platform crossovers on day 26 following ICH ( n = 12 per group, two-way ANOVA). Data are presented as mean ± SD, ** p < 0.01, *** p < 0.001 and **** p < 0.0001
Article Snippet: After being immersed in 5% non-fat milk for 2 h, the membranes were treated with primary rabbit polyclonal antibodies against OPA1 (#80,471, CST, Danvers, MA, USA), DRP1 (#8570, CST, Danvers, MA, USA), Mitofusin-1 (13,798–1-AP, Proteintech, Rosemont, Illinois, USA), Mitofusin-2 (12,186–1-AP, Proteintech, Rosemont, Illinois, USA), CD81 (27,855–1-AP, Proteintech, Rosemont, Illinois, USA), TSG101 (28,283–1-AP, Proteintech, Rosemont, Illinois, USA), GM130 (PA5-95,727, Invitrogen, Carlsbad, CA, USA) overnight at 4 °C.
Techniques: Staining, Fluorescence, Knock-Out, Adhesive